The global large molecule bioanalytical testing service market size is expected to reach USD 2.6 billion by 2027, expanding at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. The major factor attributing to market growth is the increased application of bioanalytical testing in clinical trials of biomarkers, large molecules, and others.
Rising
prevalence of HIV, infectious disease, and others has led to increasing demand
for bioanalytical testing services globally. Moreover, increasing
government initiatives to control the outbreak of various infectious diseases
such as Corona and Ebola virus is anticipated to offer more opportunities for
the market. Hence, the market is expected to grow over the assessment period.
The
market is expected to witness lucrative growth during the forecast period due
to increased research activities and the presence of a huge pipeline of
peptides, biologics, and amino acids based molecules. Additionally, bioanalysis
of large molecules requires skilled professionals with innovative analytical
instruments and infrastructure. These services are readily offered by
bioanalytical testing service providers and are likely to propel the growth of
the market during the assessment period.
North
America accounted for the highest share in 2019. The U.S. holds the highest
market share due to the increasing prevalence of various chronic diseases and
the growing adoption of large molecule therapeutics as an alternative for small
molecules.
For
example, according to International Diabetes Federation Report 2019, around
49.0 million geriatric population in the U.S. has diabetes and this has led to
increasing requests for bioanalysis of the novel (large molecule compounds)
peptide therapeutics such as glucagon-like peptide 1(GLP-1). Due to this
reason, the market is expected to show growth over the forecast period. In
addition, the presence of major players in the region contributed to market
growth.
Full Research Report On Large Molecule Bioanalytical Testing Service Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/large-molecule-bioanalytical-testing-service-market
Large Molecule
Bioanalytical Testing Service Market Report Highlights
- By type, the clinical segment held the largest
market share in 2019 owing to increasing demand for clinical trials due to
the rising prevalence of various infectious diseases
- Bioavailability held the largest market share of
20.9% in 2019 owing to increasing adoption in generic drug manufacturing
- The oncology segment held the largest revenue
share due to the increasing prevalence of cancer globally
- The U.S. is expected to witness the fastest
growth over the forecast period owing to the growing adoption of advanced
therapeutic techniques in the country.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/large-molecule-bioanalytical-testing-service-market/request/rs1
Large Molecule
Bioanalytical Testing Service Market Segmentation
Grand View Research has
segmented the global large molecule bioanalytical testing service market based
on phase, type, test type, therapeutic area, end-user, and region:
Large Molecule
Bioanalytical Testing Service Phase Outlook (Revenue, USD Million, 2016 - 2027)
- Preclinical
- With Antibody
- Without Antibody (ELISA Based Assay)
- Clinical
Large Molecule
Bioanalytical Testing Service Type Outlook (Revenue, USD Million, 2016 - 2027)
- Pharmacokinetics
- ADA
- Others
Large Molecule
Bioanalytical Testing Service Test Type Outlook (Revenue, USD Million, 2016 -
2027)
- ADME
- PK
- PD
- Bioavailability
- Bioequivalence
- Other Tests
Large Molecule
Bioanalytical Testing Service Therapeutic Area Outlook (Revenue, USD Million,
2016 - 2027)
- Oncology
- Infectious Diseases
- Cardiology
- Neurology
- Others
Large Molecule
Bioanalytical Testing Service End-user Outlook (Revenue, USD Million, 2016 - 2027)
- SMEs
- CROs & CMOs
- Sponsor Organizations
- Others (Academic institute, etc.)
- Large Firms
- CROs & CMOs
- Sponsor Organizations
- Others (Academic institute, etc.)
Large Molecule
Bioanalytical Testing Service Regional Outlook (Revenue, USD Million, 2016 -
2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Asia Pacific
- India
- Japan
- China
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
List of Key
Players of Large Molecule Bioanalytical Testing Service Market
- Covance, Inc.
- IQVIA
- Syneos Health
- SGS SA
- Toxikon
- Intertek Group plc
- Pace Analytical Services LLC
- PPD, INC.
- ICON plc
- Charles River Laboratories International
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment